Twin Lakes Capital Management, LLC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
Twin Lakes Capital Management, LLC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$20,567
-61.8%
2,1950.0%0.02%
-60.5%
Q2 2023$53,843
+5.4%
2,1950.0%0.04%0.0%
Q1 2023$51,078
-8.1%
2,1950.0%0.04%
-11.6%
Q4 2022$55,555
+32.3%
2,1950.0%0.04%
+26.5%
Q3 2022$42,000
-25.0%
2,1950.0%0.03%
+6.2%
Q1 2022$56,000
-39.1%
2,1950.0%0.03%
-34.7%
Q4 2021$92,000
-4.2%
2,1950.0%0.05%
-12.5%
Q3 2021$96,000
-7.7%
2,1950.0%0.06%
-3.4%
Q2 2021$104,0002,1950.06%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
SB INVESTMENT ADVISERS (UK) LTD 22,616,666$284,405,0003.12%
INDUS CAPITAL PARTNERS, LLC 681,936$8,575,0001.68%
Alphabet Inc. 1,666,666$20,958,0001.27%
Temasek Holdings (Private) Ltd 5,499,999$69,162,0000.45%
Board of Trustees of The Leland Stanford Junior University 38,905$490,0000.06%
Baillie Gifford 500,000$6,287,0000.01%
Marshall Wace North America L.P. 74,898$941,0000.01%
Capital International Investors 983,300$12,365,0000.00%
Blackstone Inc. 35,000$440,0000.00%
Tower Research Capital LLC (TRC) 1,908$24,0000.00%
View complete list of VIR BIOTECHNOLOGY INC shareholders